Code Biotherapeutics is an emerging next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases not well served by other gene therapy technologies.

Biotechnology

Education

Code Bio

Brian P. McVeigh

Amanda P. Skoumbourdis

Matthew Roberts

Patricia Holt

Alex T.

Alexander Tracy

Keith G. Dewedoff

Dave Anderson

Robert C. Getts

Lori A. Getts

The Leadership Team at Code Bio guides the strategic direction and overall vision of the company, focusing on advancing next-generation non-viral gene therapies. Comprising top executives, including the CEO and Chief Platform Technologies Officers, they collaborate to drive innovation, foster partnerships, and ensure operational excellence in the development of targeted treatments for serious genetic diseases.

Leadership Team

Research and Development

Business Operations

Leadership Team

About

Team members

Other teams at Code Bio

Research and Development

Business Operations